论文部分内容阅读
在过去的30年,针对蛛网膜下腔出血(SAH)的新的诊疗措施不断涌现,CT及血管造影术的问世提高了诊断的准确率,并为临床估价病程提供了一种手段;手术显微镜的应用开创了显微外科技术。近年来,由于钙离子拮抗剂尼莫地平可使SAH后病死率及重残率下降40％而被广泛应用;高血容量、血液稀释、甚至在某些情况下诱导高血压等措施也被临床应用以替代限制液体摄入及抗高血压药物等疗法(后者被发现是有
In the past 30 years, new treatments for subarachnoid hemorrhage (SAH) have emerged. The advent of CT and angiography has increased the accuracy of diagnosis and provided a means for the clinical evaluation of the disease course. The surgical microscope The application of microsurgery technology. In recent years, nimodipine, a calcium-ion antagonist, has been widely used because of the 40% reduction of post-SAH mortality and severe disability. High blood volume, hemodilution, and even hypertension in some cases have also been reported Application Alternatives to treatments such as limiting fluid intake and antihypertensives (the latter found to be true)